Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


AZ hits back at travel ban panic

Posted 4 August 2021 AM

AstraZeneca's local division has poured water on claims the Australian manufactured vaccine might be knocked back as invalid by some European countries.

The company's response follows a string of reports in both local and international mainstream media that non-EU produced versions of the vaccine,  now to be universally-named Vaxzevria, may not be recognised in the EU.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Melb pharma registers first copy
Long list of generic versions of PBS-listed drugs